Donanemab

• CAS Number :

  1931944-80-7

• Target :

  Beta Amyloid|||Microtubule Associated

• Related Pathways :

  Cytoskeletal Signaling|||Neuroscience

• Purity :

  0.9919

• Bioactivity :

  Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody that targets a pyroglutamate amyloid beta (A?) epitope at the N-terminus, showing potential for early Alzheimer's disease research [1] [2].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C